These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1973334)

  • 1. Current status and future goals of the pharmacologic reduction of portal hypertension.
    Lebrec D
    Am J Surg; 1990 Jul; 160(1):19-25. PubMed ID: 1973334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term pharmacologic therapy of portal hypertension.
    Burroughs AK; McCormick PA
    Surg Clin North Am; 1990 Apr; 70(2):319-39. PubMed ID: 1969683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiological and pharmacotherapeutic aspects of portal hypertension].
    Sieber CC; Stalder GA
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):3-13. PubMed ID: 8093646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers.
    Bursey RF
    Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
    [No Abstract]   [Full Text] [Related]  

  • 8. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in portal hypertension: new developments and controversies.
    Tripathi D; Hayes PC
    Liver Int; 2014 May; 34(5):655-67. PubMed ID: 24134058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
    Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockers in portal hypertension--current status.
    Koshy A
    Trop Gastroenterol; 1989; 10(3):142-7. PubMed ID: 2573188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of portal hypertension].
    Lebrec D
    Presse Med; 1991 Apr; 20(16):750-5. PubMed ID: 1675466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of portal hypertension.
    Rodríguez-Pérez F; Groszmann RJ
    Gastroenterol Clin North Am; 1992 Mar; 21(1):15-40. PubMed ID: 1349005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta blockaders and portal hypertension].
    Lebrec D
    Rev Prat; 1989 Apr; 39(13):1154-8. PubMed ID: 2567529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.